Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Interpretation of Hematological, Biochemical, and Immunological Findings of Covid-19 Disease: Biomarkers Associated With Severity and Mortality Publisher Pubmed



Ghazanfari T1 ; Salehi MR2, 20, 21 ; Namaki S3 ; Arabkheradmand J4 ; Rostamian A5 ; Rajabnia Chenary M6, 12 ; Ghaffarpour S7, 17, 22, 26 ; Kaboudanian Ardestani S8 ; Edalatifard M9 ; Naghizadeh MM10 ; Mohammadi S11 ; Mahloujirad M6, 12 ; Izadi A13 ; Ghanaati H14 Show All Authors
Authors
  1. Ghazanfari T1
  2. Salehi MR2, 20, 21
  3. Namaki S3
  4. Arabkheradmand J4
  5. Rostamian A5
  6. Rajabnia Chenary M6, 12
  7. Ghaffarpour S7, 17, 22, 26
  8. Kaboudanian Ardestani S8
  9. Edalatifard M9
  10. Naghizadeh MM10
  11. Mohammadi S11
  12. Mahloujirad M6, 12
  13. Izadi A13
  14. Ghanaati H14
  15. Beigmohammadi MT15, 19
  16. Vodjgani M16
  17. Mohammad Shirazi B7, 17, 22, 26
  18. Mirsharif ES7, 17, 22, 26
  19. Abdollahi A18
  20. Mohammadi M15, 19
  21. Emadi Kouchak H2, 20, 21
  22. Dehghan Manshadi SA2, 20, 21
  23. Zamani MS7, 17, 22, 26
  24. Mahmoodi Aliabadi M23
  25. Jamali D24
  26. Khajavirad N25
  27. Mohseni Majd AM7, 17, 22, 26
  28. Nasiri Z7, 17, 22, 26
  29. Faghihzadeh S27
Show Affiliations
Authors Affiliations
  1. 1. Immunoregulation Research Center, Shahed University, Iran AND Simorgh Clinical Laboratory, Tehran, Iran
  2. 2. Department of Infectious Diseases, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  4. 4. Ahya Neuroscience Research Center, Tehran, Iran
  5. 5. Department of Rheumatology, Valiasr Hospital, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Simorgh Clinical Laboratory, Tehran, Iran
  7. 7. Immunoregulation Research Center, Shahed University, Tehran, Iran
  8. 8. Department of Immunology, Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran
  9. 9. Thoracic Research Center, Tehran University of Medical Sciences, Tehran, Iran
  10. 10. Immunoregulation Research Center, Shahed University, Iran AND Non-communicable diseases Research Center, Fasa University of Medical Sciences, Fasa, Tehran, Iran
  11. 11. Hematology-Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran
  12. 12. Simorgh Clinical Laboratory, Tehran, Iran
  13. 13. Department of Medical Mycology and Parasitology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  14. 14. Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Tehran University of Medical Sciences, Tehran, Iran
  15. 15. Department of Anesthesiology and Intensive Care, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
  16. 16. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  17. 17. Immunoregulation Research Center, Shahed University, Tehran, Iran
  18. 18. Department of Pathology, School of Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
  19. 19. Department of Anesthesiology and Intensive Care, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
  20. 20. Department of Infectious Diseases, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  21. 21. Department of Infectious Diseases, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  22. 22. Immunoregulation Research Center, Shahed University, Tehran, Iran
  23. 23. Department of Laboratory, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
  24. 24. Department of Immunology, Shahed University, Tehran, Iran
  25. 25. Department of Internal Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
  26. 26. Immunoregulation Research Center, Shahed University, Tehran, Iran
  27. 27. Department of Biostatistics and Social Medicine, Zanjan University of Medical Sciences, Zanjan, Iran

Source: Iranian journal of allergy# asthma# and immunology Published:2021


Abstract

The severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) spread rapidly all over the world in late 2019 and caused critical illness and death in some infected patients. This study aimed at examining several laboratory factors, especially inflammatory and immunological mediators, to identify severity and mortality associated biomarkers. Ninety-three hospitalized patients with confirmed coronavirus disease 2019 (COVID-19) were classified based on disease severity. The levels of biochemical, hematological, immunological, and inflammatory mediators were assessed, and their association with severity and mortality were evaluated. Hospitalized patients were mostly men (77.4%) with an average (standard deviation) age of 59.14 (14.81) years. The mortality rate was significantly higher in critical patients (85.7%). Increased serum levels of blood sugar, urea, creatinine, uric acid, phosphorus, total bilirubin, serum glutamic-oxaloacetic transaminase, serum glutamic-oxaloacetic transaminase, lactic dehydrogenase, C-reactive protein, ferritin, and procalcitonin were significantly prevalent (p=0.002, p<0.001, p<0.001, p=0.014, p=0.047, p=0.003, p<0.001, p<0.001, p<0.001, p<0.001, P<0.001, and p<0.001, respectively) in COVID-19 patients. Decreased red blood cell, hemoglobin, and hematocrit were significantly prevalent among COVID-19 patients than healthy control subjects (p<0.001 for all). Troponin-I, interleukin-6, neutrophil/lymphocyte ratio (NLR), procalcitonin, and D-dimer showed a significant association with the mortality of patients with specificity and sensitivity more than 60%. Age, sex, underlying diseases, blood oxygen pressure, complete blood count along with C-reactive protein, lactic dehydrogenase, procalcitonin, D-dimer, and interleukin-6 evaluation help to predict the severity and required management for COVID-19 patients. Further investigations are highly recommended in a larger cohort study for validation of the present findings.